{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:00:55Z","timestamp":1778367655756,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jcrc.2023.154453","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T23:16:35Z","timestamp":1698275795000},"page":"154453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring the orepinephrine to ngiotensin II onversion atio in atients with asodilatory ypotension: A ost-oc nalysis of the ARAMIS rial"],"prefix":"10.1016","volume":"79","author":[{"given":"Emily J.","family":"See","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Chaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Spano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Clapham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Khasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Liskaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2023.154453_bb0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2023.154453_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00134-022-06928-2","article-title":"Machine-learning-derived sepsis bundle of care","volume":"49","author":"Kalimouttou","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0020","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jvs.2018.01.050","article-title":"Causes and outcomes of finger ischemia in hospitalized patients in the intensive care unit","volume":"68","author":"Landry","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcrc.2023.154453_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2020.10.023","article-title":"Predictors of dysrhythmias with norepinephrine use in septic shock","volume":"61","author":"Wieruszewski","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of Catecholamine Dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock*","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin ii as primary vasopressor in critically ill adults with vasodilatory hypotension: the Aramis study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2023.154453_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: a scoping review and suggested formula","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcp.14969","article-title":"Dose equivalence between metaraminol and norepinephrine in critical care","volume":"88","author":"Abu Sardaneh","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154453_bb0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-022-06652-x","article-title":"Dose of norepinephrine: the devil is in the details","volume":"48","author":"Leone","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery*","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jcrc.2023.154453_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13054-023-04500-y","article-title":"Adjunctive vasopressors in distributive shock: how soon is early?","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154453_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2023.154453_bb0095","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s00134-022-06808-9","article-title":"How can assessing hemodynamics help to assess volume status?","volume":"48","author":"De Backer","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154453_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-022-04230-7","article-title":"Continuous bladder urinary oxygen tension as a new tool to monitor medullary oxygenation in the critically ill","volume":"26","author":"Hu","year":"2022","journal-title":"Crit Care"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123002022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123002022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:31Z","timestamp":1760125951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944123002022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":20,"alternative-id":["S0883944123002022"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154453","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154453"}}